Muscle Function and Strength Training of the Neck and Shoulder in Migraine and Tension-type Headache Patients. A Singel Arm Open Label Trial (MUST-MITH)

October 27, 2023 updated by: Bjarne Kjeldgaard Madsen, Danish Headache Center

Muscle Function and Strength Training of the Neck and Shoulder in Migraine and Tension-type Headache Patients.

A Single-Arm Open-Label Trial was performed at the Danish Headache Center (DHC), Department of Neurology, Rigshospitalet - Glostrup as part of the clinic.

Purpose:

To examine the effects of supervised group strength training and posture correction on headache frequency and muscle function around the neck and shoulders in patients with migraine and tension-type headaches.

Hypothesis:

Strength training of the neck and shoulders results in improved muscle function, which leads to a reduction in headache.

Study Overview

Status

Active, not recruiting

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

30

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Glostrup, Denmark, 2600
        • Danish Headache Center Rigshospitalet - Glostrup

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Migraine patients with stable CGRP or botox.
  • Tension type headache with no more than 5 migraine days/month.
  • At least four days/months of headache at the moment of recruitment.

Exclusion Criteria:

  • Pregnancy
  • Post-traumatic headache, or headache that is likely to be associated with trauma.
  • Significant psychiatric comorbidities, such as severe depression
  • Medication Overuse Headaches.
  • Severe arthrosis in the neck, shoulder, or disc herniation in the neck.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Migraine and tension-type headache patients
Patients diagnosed by a neurologist following the 3rd edition of the International Classification of Headaches Disorders (ICHD-III)
A targeted 8-week strength-training course was offered as an intervention in combination with ergonomics and posture corrections and recommendations

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
headache frequency
Time Frame: two weeks prior to intervention, last two weeks of intervention
number of days with headache
two weeks prior to intervention, last two weeks of intervention

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
neck pain maximal intensity
Time Frame: two weeks prior to intervention, last two weeks of intervention, and weeks 4 and 5 after intervention
maximal neck pain intensity percieved by patient in a 0-10 NRPS
two weeks prior to intervention, last two weeks of intervention, and weeks 4 and 5 after intervention
neck pain average intensity
Time Frame: two weeks prior to intervention, last two weeks of intervention, and weeks 4 and 5 after intervention
average neck pain intensity percieved by patient in a 0-10 NRPS
two weeks prior to intervention, last two weeks of intervention, and weeks 4 and 5 after intervention
neck pain frequency
Time Frame: two weeks prior to intervention, last two weeks of intervention, and weeks 4 and 5 after intervention
number of days with neck pain
two weeks prior to intervention, last two weeks of intervention, and weeks 4 and 5 after intervention
headache duration
Time Frame: two weeks prior to intervention, last two weeks of intervention, and weeks 4 and 5 after intervention
hours with headache
two weeks prior to intervention, last two weeks of intervention, and weeks 4 and 5 after intervention
medication intake
Time Frame: two weeks prior to intervention, last two weeks of intervention, and weeks 4 and 5 after intervention
number of days with medication for pain taked
two weeks prior to intervention, last two weeks of intervention, and weeks 4 and 5 after intervention
Functional level
Time Frame: Before intervention, after intervention and at 1 month follow up
Self-reported limitated activities due to headache in a 0-10 scale thourgh the Patient-Specific Functional Scale
Before intervention, after intervention and at 1 month follow up
Headache average Intensity
Time Frame: two weeks prior to intervention, last two weeks of intervention, and weeks 4 and 5 after intervention
average headache intensity percieved by patient in a 0-10 NRPS
two weeks prior to intervention, last two weeks of intervention, and weeks 4 and 5 after intervention
Headache maximal Intensity
Time Frame: two weeks prior to intervention, last two weeks of intervention, and weeks 4 and 5 after intervention
maximal headache intensity percieved by patient in a 0-10 NRPS
two weeks prior to intervention, last two weeks of intervention, and weeks 4 and 5 after intervention
headache frequency
Time Frame: weeks 4 and 5 after intervention
number of days with headache
weeks 4 and 5 after intervention

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Maximal Voluntary Contraction of the Neck extension
Time Frame: Before intervention, after intervention and at 1 month follow up
Maximal force of the neck extension (Newtons)
Before intervention, after intervention and at 1 month follow up
Maximal Voluntary Contraction of the Neck flexion
Time Frame: Before intervention, after intervention and at 1 month follow up
Maximal force of the neck flexion (Newtons)
Before intervention, after intervention and at 1 month follow up
Maximal Voluntary Contraction of the Shoulder elevation
Time Frame: Before intervention, after intervention and at 1 month follow up
Maximal force of the shoulder elevation (Newtons)
Before intervention, after intervention and at 1 month follow up
Moment arm for neck flexion and extension
Time Frame: Before intervention
Distance between C7 and Protuberancia occipitalis (m)
Before intervention
Moment arm for shoulder elevation
Time Frame: Before intervention
Distance between C7 and acromion of the right shoulder (m)
Before intervention
Moment arm for neck flexion
Time Frame: Before intervention, after intervention and at 1 month follow up
Peak of the Maximal Voluntary Contraction x Moment arm of the neck flexion (N*m)
Before intervention, after intervention and at 1 month follow up
Moment arm of the neck extension
Time Frame: Before intervention, after intervention and at 1 month follow up
Peak of the Maximal Voluntary Contraction x Moment arm of the neck extension (N*m)
Before intervention, after intervention and at 1 month follow up
Moment arm fof the shoulder elevation
Time Frame: Before intervention, after intervention and at 1 month follow up
Peak of the Maximal Voluntary Contraction x Moment arm of the shoulder elevation (N*m)
Before intervention, after intervention and at 1 month follow up
Extension-Flexion ratio
Time Frame: Before intervention, after intervention and at 1 month follow up
Ratio between moment arm of the neck extension and moment arm of the neck flexion.
Before intervention, after intervention and at 1 month follow up
Rate of force development of the shoulder elevation
Time Frame: Before intervention, after intervention and at 1 month follow up
(75% of the peak value of the shoulder elevation (N) - 25% of the peak value of the shoulder elevation)/(time at de 75% of the peak of shoulder elevation (s) - time at 25% of the peak of shoulder elevation) in Newtons per second (N/s)
Before intervention, after intervention and at 1 month follow up
Early rate of force development of the shoulder elevation
Time Frame: Before intervention, after intervention and at 1 month follow up
(Value of the peak of the shoulder elevation at 250ms after the 2,5% of the peak (N) - 2,5% of the peak value of the shoulder elevation)/0,250 (s) in Newtons per second (N/s)
Before intervention, after intervention and at 1 month follow up
Muscle tenderness
Time Frame: Before intervention, after intervention and at 1 month follow up
Total Tenderness Score (0-48)
Before intervention, after intervention and at 1 month follow up
Muscle tenderness of the face
Time Frame: Before intervention, after intervention and at 1 month follow up
Total Tenderness Score of the first 4 spots: masseter, coronoid process, temporalis and frontalis (0-24)
Before intervention, after intervention and at 1 month follow up
Muscle tenderness of the neck
Time Frame: Before intervention, after intervention and at 1 month follow up
Total Tenderness Score of the last 4 spots: mastoid process, sternocleidmastoid, occipitalis and superior trapezius (0-24)
Before intervention, after intervention and at 1 month follow up
Craniocervical flexion score
Time Frame: Before intervention, after intervention and at 1 month follow up
Craniocervical flexion test score. Possible values: 20, 22, 24, 26, 28 or 30 mmHg
Before intervention, after intervention and at 1 month follow up
Exercise sessions completed
Time Frame: During the intervention
Number of training sessions performed by the participants
During the intervention
Percieved intensity
Time Frame: During the intervention
Level of intensity percieved by patients in each exercise session
During the intervention
Intensity coherence
Time Frame: post-intervention
Ratio between average of rate of percieved exertion by the patients and 10 (coefficient from 0 to 1).
post-intervention
Adherence of the programm
Time Frame: post-intervention
Ratio between the number of exercise sessions completed by patients versus number of exercise sessions planned in the programm
post-intervention
Adherence to exercise
Time Frame: Week 1 to 5 after intervention
Ratio between the number of exercise sessions completed after intervention until the follow-up.
Week 1 to 5 after intervention
Compliance of the programm
Time Frame: post-intervention
Product between intensity coherence and adherence.
post-intervention

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 6, 2023

Primary Completion (Estimated)

May 15, 2024

Study Completion (Estimated)

May 15, 2024

Study Registration Dates

First Submitted

October 10, 2023

First Submitted That Met QC Criteria

October 27, 2023

First Posted (Actual)

November 1, 2023

Study Record Updates

Last Update Posted (Actual)

November 1, 2023

Last Update Submitted That Met QC Criteria

October 27, 2023

Last Verified

October 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

all IPD that underlie results in a publication

IPD Sharing Time Frame

At the moment of publication and thereafter

IPD Sharing Access Criteria

After its publication, according to the journal's policy and under the consensus of all authors.

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • CSR

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Migraine

Clinical Trials on strength training

Subscribe